This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Philip Gotwals
Global Head, Business Development and Licensing at Novartis Institutes for BioMedical Research, Inc.


Philip Gotwals is Global Head, BD&L, at Novartis Institutes for BioMedical Research (NIBR) where he oversees business development efforts for all disease areas and technology platforms. Previously, Phil was Executive Director, Exploratory Immuno-Oncology, and instrumental in building NIBR’s immuno-oncology strategic research area including the CAR-T platform. He has more than 20 years of experience in the biotechnology and pharmaceutical industries, leading internal and collaborative R&D programs from drug discovery to new drug application filing, and leading the licensing of product candidates.  Phil holds a Ph.D. in genetics from the University of California at Berkeley, and completed postdoctoral research at the Massachusetts Institute of Technology.

Agenda Sessions

  • Featured Presentation - NIBR BD&L: Innovation Through Partnering